Marianne De Email & Phone

Chief Executive Officer @ Vir Biotechnology, Inc.

R and D Group leader, Principal scientist Gastrointestinal Emerging Diseases @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Project leader, Senior scientist Advanced BioTechnologies @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Founding Board Member University Ghent alumni and Chapter USA West @ Ghent University

Member Board Of Directors, Gladstone Foundation @ Gladstone Institutes

Member Board Of Directors @ Kronos Bio, Inc.

Member Board of Directors @ Arrowhead Pharmaceuticals

Member of the Executive Committee, EVP, Global Head Strategy, BD and L and Open Innovation (CBO) @ Bayer

Member of the Executive Committee, EVP, Global Head Strategy and Business Development (CBO) @ Bayer

Member Board Of Directors @ BlueRock Therapeutics

Vice-Chair Board of Directors (a Bayer company) @ Vividion Therapeutics. Inc.

Member Board Of Directors (a Bayer company) @ Asklepios BioPharmaceutical, Inc. (AskBio)

Member, Board Of Directors Ecohealth Alliance (non for profit) @ EcoHealth Alliance

Advisory Board Member @ Biocom

Global Vice President, M and A Ops, Divestitures and IDV BD @ Johnson & Johnson

Instructor Business and Finance Perspectives of the Biotechnology Industry @ San Jose State University

Vice President, Venture Investments, JJDC @ Johnson & Johnson

Vice President, Johnson and Johnson Innovation - Janssen Business Development @ Johnson & Johnson

BUSINESS UNIT LEADER @ The Janssen Pharmaceutical Companies of Johnson & Johnson

VICE PRESIDENT Licensing and New Business Development NEUROSCIENCES @ Janssen, Pharmaceutical Companies of Johnson and Johnson

VICE PRESIDENT Licensing, R and D Internal Medicine and Neurosciences @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Executive Director Scientific and Business Licensing VIROLOGY worldwide @ Tibotec

Director TECHNOLOGY LICENSING @ Janssen, Pharmaceutical Companies of Johnson and Johnson

R and D Group leader (US based team), Senior scientist IMMUNOLOGY @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Scientist, Experimental Molecular Biology @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Senior Associate Scientist, Biochemical Pharmacology @ Janssen, Pharmaceutical Companies of Johnson and Johnson

Traineeship (Prof. Fiers lab) @ Ghent University

2017 - 2017 Private Equity and Venture Capital @ Harvard Business School

2016 - 2016 Board certification @ The George Washington University

2016 - 2016 Mergers & Acquisitions @ University of Pennsylvania - The Wharton School

2015 - 2015 Value investing (online) @ Stanford Continuing Studies

2010 - 2010 Corporate Level Strategy @ Harvard Business School

2010 - 2010 Leading the Effective Sales Force @ INSEAD

2009 - 2009 Finance for Executives @ INSEAD

2002 - 2004 Master of Business Administration - MBA @ Rotterdam School of Management, Erasmus University

1998 - 2001 PhD in Biotechnology @ Ghent University

1992 - 1994 Master's Degree @ Vrije Universiteit Brussel

1987 - 1991 Master's degree in Engineering @ Ghent University

Marianne De, based in San Francisco, CA, US, is currently a Chief Executive Officer at Vir Biotechnology, Inc.. Marianne De brings experience from previous roles at Janssen, Pharmaceutical Companies of Johnson and Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Ghent University, Gladstone Institutes, Kronos Bio, Inc., Arrowhead Pharmaceuticals, Bayer, Bayer, BlueRock Therapeutics, Vividion Therapeutics. Inc., Asklepios BioPharmaceutical, Inc. (AskBio), EcoHealth Alliance, Biocom, Johnson & Johnson, San Jose State University, Johnson & Johnson, Johnson & Johnson, The Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Tibotec, Janssen, Pharmaceutical Companies of Johnson and Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Janssen, Pharmaceutical Companies of Johnson and Johnson, Ghent University. Marianne De holds various educational qualifications including Private Equity and Venture Capital (2017 - 2017) from Harvard Business School. With a robust skill set that includes a diverse set of professional skills, Marianne De demonstrates proficiency in a wide range of areas.